Jupiter neurosciences, inc. announces pricing of $11 million initial public offering and listing on nasdaq

Jupiter, florida, dec. 02, 2024 (globe newswire) -- jupiter neurosciences, inc. (nasdaq: juns) (the “company” or “jupiter neurosciences”), a clinical stage pharmaceutical company advancing a pipeline targeting neuroinflammation with its unique resveratrol platform product, jotrol™, today announced the pricing of its initial public offering (the “offering”) of 2,750,000 shares of common stock at a price of $4.00 per share.
NDAQ Ratings Summary
NDAQ Quant Ranking